ABIONYX Pharma SA (EPA:ABNX)
3.540
-0.050 (-1.39%)
Apr 28, 2026, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €124.88 million as of April 28, 2026. Its market cap has increased by 203.65% in one year.
Market Cap
124.88M
Enterprise Value
125.63M
Revenue
4.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.54
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 124.88M, a decrease of -41.69%. That is a compound annual growth rate of -4.75%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 105.09M |
| MaaT Pharma | 102.89M |
| Adocia | 90.87M |
| Sensorion | 194.82M |
| Transgene | 207.33M |
| Valerio Therapeutics Société anonyme | 76.26M |
| OSE Immunotherapeutics | 67.80M |
| Cellectis | 239.99M |